InternationalUSRemember you can easily switch between MIP US and MIP International at any time

European Commission claims pharma competition success

Legal Media Group


The proportion of problematic patent settlements in the pharmaceutical industry has fallen, even though the number of settlements has grown, according to the European Commission

In a statement published on January 31, the Commission said that its third annual survey had found that 11% of antitrust settlements were potentially problematic from an antitrust point of view, compared to 21% when the pharmaceutical sector enquiry was conducted in 2008 to 2009.

That came as the total number of settlements reached 120 in 2011,...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of one week’s FREE access and become a Managing IP member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain 7 days FREE access when you register now.

Join here

profile

Managing IP

ManagingIP

ManagingIP profile

We're getting some interesting comments on our blog on #graceperiods Anything to add? Join the debate here http://t.co/VbMvAi0LpK #patent

Oct 30 2014 09:31 ·  reply ·  retweet ·  favourite
ManagingIP profile

RT @LeeMarkDavies: bad faith trade mark applications a common theme for all @The_IPO attachés @IPaware #IPAN @TheCIPA

Oct 29 2014 05:30 ·  reply ·  retweet ·  favourite
ManagingIP profile

£25 billion in bank lending backed by IP rights in China last year - Tom Duke at @IPaware @TheCIPA event. Can/should other countries follow?

Oct 29 2014 05:26 ·  reply ·  retweet ·  favourite
More from the Managing IP blog


AIPLA Daily Report 2014

Read this year's AIPLA Daily Report - published daily by Managing IP direct from the AIPLA Annual Meeting in Washington DC


null null null

October 2014

What we want from the Unitary Patent and UPC

The EU Unitary Patent and Unified Patent Court are set to launch within the next 18 months. In the first article of a year-long series, Emma Barraclough and James Nurton gauge the expectations and concerns of in-house counsel



Most read articles

Supplements